
Fellow cancer survivor Melisa Etheridge's song "I Run for Life" has gained a permanent spot on my running playlist because it reminds me why I run.
Fellow cancer survivor Melisa Etheridge's song "I Run for Life" has gained a permanent spot on my running playlist because it reminds me why I run.
At the end of the day, it is the patient who gets to decide what kind of medical treatment is best for them. Doctors may not always like their choice.
Explaining our cancer to the rest of the world.
We should not assume that people diagnosed with metastatic disease will want to quit work. We need to ask patients with newly diagnosed metastatic disease how they view and value their jobs.
Hope? Several years out, a breast cancer and melanoma survivor contemplates what comforted her and could have comforted at the time of diagnosis and early in her treatment.
Am I alone in wanting to reassure everyone I meet?
The designation, which will expedite the development and review of sacituzumab govitecan in TNBC, is based on a phase 2 trial in which the therapy induced a response rate of 31 percent in heavily pretreated patients with metastatic TNBC.
Learning to accept my body after a double mastectomy.
These data were presented in mid-December 2015.
Following doctors orders is what we're supposed to do, but sometimes it's a personal choice.
Exercise, protein, belief and visualization are my not-so-secret weapons in my life with metastatic breast cancer.
A male breast cancer survivor shares his humorous twist to health and healing.
A cancer survivor wonders if chemicals contributed to her breast cancer or melanoma.
In an interview with CURE, Anees B. Chagpar, from The Breast Center at Smilow Cancer Hospital at Yale-New Haven, shares her thoughts on the final guidelines and how they change the focus of screening.